|
Primary and secondary outcome parameters |
|
| OUTCOME PARAMETERS I |
OUTCOME PARAMETERS II |
| DMP 1 vs. DMP 2 |
DMP 1 vs. CG |
|
|
|
| Primary outcome parameter |
Primary outcome parameter |
|
|
|
| Proportion of patients achieving target values for HbA1c and RR according to the legal regulations (10) |
Proportion of patients with prescriptions for antidiabetic, antihypertensive and lipid-lowering drugs |
|
|
|
| Secondary outcome parameters |
Secondary outcome parameters |
|
|
|
| Proportion of patients with prescriptions for antidiabetic, antihypertensive and lipid-lowering drugs |
---- |
| Proportion of patients with referrals to ophthalmologists, specialists for diabetology and diabetic feet |
Proportion of patients with referrals to ophthalmologists, specialists for diabetology and diabetic feet |
| Proportion of patients referred to a patient education training for diabetes and hypertension |
Proportion of patients referred to a patient education training for diabetes and hypertension |
| Proportion of patients with severe complications (amputation, dialysis etc.) |
Proportion of patients with severe complications (amputation, dialysis etc.) |
| Proportion of patients with > 2 hospitalizations in the last 6 months |
Proportion of patients with > 2 hospitalizations in the last 6 months |
| Consultation rate |
Consultation rate |
| Days of incapacity to work |
Days of incapacity to work |
| Mean differences of HbA1c, RR, BMI and glomerular filtration rate |
--- |
| SCORE risk chart (RR, cholesterol, smoking status, age, gender) |
--- |
| Drop out rate from the DMP |
--- |
Joos et al. BMC Public Health 2005 5:99 doi:10.1186/1471-2458-5-99 |
|